Skip to main content

Advertisement

Table 3 Percentages of splenocyte populations (CD45, CD4, CD8, CD197, CD62L, CD27, B220) in untreated BALB/c mice, treated with AA0029+Qs and immunised with AA0029+Qs+rFh15 and AA0029+Qs+rFh15b 2 weeks after immunisation schedule. Data presented as the mean ± standard error of the mean

From: Protection against Schistosoma mansoni infection using a Fasciola hepatica-derived fatty acid binding protein from different delivery systems

Cell population Untreated (%) AA0029+Qs (%) AA0029+Qs+rFh15 (%) AA0029+Qs+rFh15b (%)
CD45 75.7 ± 3.4 77.0 ± 0.7 75.5 ± 2.8 66.7 ± 1.3
CD4 21.1 ± 1.3 20.7 ± 0.4 21.3 ± 0.5 21.7 ± 4.0
CD8 8.4 ± 0.5 8.4 ± 0.6 10.2 ± 0.6 9.5 ± 1.3
CD197 16.9 ± 1.7 18.0 ± 2.1 12.6 ± 2.8 14.9 ± 0.6
CD62L 23.2 ± 3.2 20.1 ± 5.0 17.2 ± 0.9 15.2 ± 5.0
CD27 19.4 ± 1.9 18.0 ± 1.6 16.9 ± 0.8 16.7 ± 3.6
B220 35.9 ± 3.2 39.4 ± 0.6 23.2 ± 1.7 21.3 ± 0.7*
  1. *Significant differences in comparison with untreated group P < 0.001 (Kruskal-Wallis χ 2 = 15.51, df = 3, P = 0.001)